1 January 2025 in Medical and Pharmaceutical Journal
Background: Parkinson's disease is a chronic central nervous system disorder that is primarily marked by motor symptoms, which include tremor, decreased movement, muscle rigidity, and loss of balance. Impulse Control Disorders (ICDs) are serious non-motor side effects associated with dopamine agonist (DA) therapy in Parkinson’s disease (PD). Objective: This study investigated the structural and functional neural correlates of ICDs in PD patients on DA treatment using multimodal neuroimaging. Methods: Sixty participants (30 with ICDs, 30 matched controls) underwent clinical assessments, structural MRI, resting-state fMRI, and task-based fMRI during a monetary incentive delay task. Results: Structural MRI revealed reduced grey matter volume in the right orbitofrontal cortex (OFC) in the ICD group. Resting-state fMRI showed hyperconnectivity between the nucleus accumbens (NAcc) and medial prefrontal cortex (mPFC), and reduced anticorrelation between the OFC and dorsal anterior cingulate cortex (dACC). Task-based fMRI demonstrated blunted ventral striatal activation during reward anticipation but heightened OFC activation during outcome processing. Conclusion: These multimodal findings support a model of ICDs involving both reward system hyperactivity and impaired inhibitory control. The combined use of structural, resting-state, and task-based fMRI in the same cohort offers novel insights and potential biomarkers for early detection and targeted interventions.